QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients

This study aimed to determine whether increased QT interval variability is associated with an increased risk for ventricular tachycardia (VT) or ventricular fibrillation (VF), documented by interrogation of the implantable cardioverter-defibrillator (ICD), in patients enrolled in the Multicenter Aut...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2004-10, Vol.44 (7), p.1481-1487
Main Authors: Haigney, Mark C., Zareba, Wojciech, Gentlesk, Philip J., Goldstein, Robert E., Illovsky, Michael, McNitt, Scott, Andrews, Mark L., Moss, Arthur J.
Format: Article
Language:English
Subjects:
Aged
Algorithms
Biological and medical sciences
Cardiac arrhythmia
Cardiac dysrhythmias
Cardiology
Cardiology. Vascular system
Clinical Trials as Topic
Confidence intervals
Defibrillators, Implantable
Diabetes
Electrocardiography
Female
Heart
Heart attacks
Heart Conduction System - physiopathology
Heart rate
Humans
Logistic Models
Male
Medical sciences
Middle Aged
Mortality
Multicenter Studies as Topic
Odds Ratio
Proportional Hazards Models
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
Risk Assessment
Risk Factors
Tachycardia, Ventricular - etiology
Tachycardia, Ventricular - mortality
Tachycardia, Ventricular - physiopathology
Tachycardia, Ventricular - therapy
Time series
Ventricular Fibrillation - etiology
Ventricular Fibrillation - mortality
Ventricular Fibrillation - physiopathology
Ventricular Fibrillation - therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study aimed to determine whether increased QT interval variability is associated with an increased risk for ventricular tachycardia (VT) or ventricular fibrillation (VF), documented by interrogation of the implantable cardioverter-defibrillator (ICD), in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II. Unstable repolarization has been proposed as a risk factor for re-entrant arrhythmias, but confirmatory data from clinical trials are lacking. The QT variability was assessed in 10-min, resting high-resolution electrocardiogram recordings at study entry using a semiautomated algorithm that measured beat-to-beat QT duration in 817 MADIT II patients. The incidence of VT/VF requiring device therapy was determined by ICD interrogation. Median normalized QT variability (QTVN) was 0.179 and 0.125, respectively, in patients with VT/VF versus those without VT/VF (p = 0.001); QTVI (QTVN adjusted for heart rate variance) also was significantly (p < 0.05) higher in VT/VF patients than in those without VT/VF. Either QTVN or QTVI was linked with a significantly higher probability of VT/VF: two-year risk of VT/VF from Kaplan-Meier curves was 40% in highest quartile versus 21% in lower quartiles for QTVN, and 37% versus 22% for QTVI (p < 0.05 for each). In multivariate Cox regression models adjusting for clinical covariates (race, New York Heart Association functional class, time after myocardial infarction), top-quartile QTVI and QTVN were independently associated with VT/VF (hazard ratio for QTVN 2.18, 95%confidence interval [CI] 1.34 to 3.55, p = 0.002; hazard ratio for QTVI 1.80, 95% CI 1.09 to 2.95, p = 0.021). In postinfarction patients with severe left ventricular dysfunction, increased QT variability, a marker of repolarization lability, is associated with an increased risk for VT/VF.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2004.06.063